Moderna/Merck cancer vaccine shows promise in trials
In an encouraging development for the concept of using vaccines to fight cancer, a personalized messenger RNA (mRNA) cancer vaccine jointly developed by Moderna and Merck Co. has shown positive results in a randomized Phase 2 clinical trial, the companies announced Dec. 13.
Read the entire article here on Chemical & Engineering News.
Recent News & Updates
Bills to limit pharmacy benefit managers have been among the most popular and bipartisan pieces of legislation introduced in Congress during the last two years, yet none have passed.
Bob Lane, a prostate cancer survivor and patient receiving Erleada (apalutamide), understands firsthand the challenges men face when discussing prostate cancer.
We’ve all experienced common issues like headaches, vision changes, nausea, stomach pain, and mouth sores.
A string of recent rural health clinic closures is threatening to further reduce access to care in outlying areas as health systems brace for cuts in the in the Republican budget law and grapple with inflation and workforce issues.
